Phase III Multicenter Placebo|Controlled Study of Tamsulosin in ...

Phase III multicenter placebo-controlled study of tamsulosin in ...

Tamsulosin was effective, safe, and well tolerated in the target BPH population at both the 0.4- and 0.8-mg/day dose levels, without the blood ...

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in ...

Tamsulosin was effective, safe, and well tolerated in the target BPH population at both the 0.4- and 0.8-mg/day dose levels, without the blood pressure- ...

PHASE III MULTICENTER PLACEBO-CONTROLLED STUDY OF ...

The double-blind treatment phase lasted a total of 13 weeks. Patients randomized to tamsulosin 0.8 mg/day re- ceived tamsulosin 0.4 mg/day for 1 ...

A SECOND PHASE III MULTICENTER PLACEBO CONTROLLED ...

In our study efficacy of symptom improvement was not statistically significant between tamsulosin doses of 0.4 and 0.8 mg., which suggests that tamsulosin at a ...

A comparison of two phase III multicenter, placebo-controlled ...

In two large, multicenter, double-blind, parallel, US phase III clinical trials, men with benign prostatic hyperplasia were randomized to receive tamsulosin ...

Long-term, open-label, phase III multicenter study of tamsulosin in ...

The primary efficacy parameters were the changes in the total American Urological Association (AUA) symptom score, mean peak urinary flow rate (Qmax), and ...

A 6-month large-scale study into the safety of tamsulosin - PMC

A multicentre, open-label phase IIIb study with 1784 patients receiving 0.4 mg o.d. tamsulosin for 6 months was performed according to good clinical practice ...

A SECOND PHASE III MULTICENTER PLACEBO CONTROLLED ...

Tamsulosin was safe and effective, and clinically and statistically superior to placebo in relieving symptoms of benign prostatic hyperplasia in men with ...

Phase III multicenter placebo-controlled study of tamsulosin in ...

Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract ...

Phase III Multicenter Placebo-Controlled Study of Tamsulosin ... - Scilit

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia · journal article · clinical trial · Published by Elsevier in Urology.

A comparison of two phase III multicenter, placebo-controlled ...

ABSTRACT. In two large, multicenter, double-blind, parallel, US phase III clinical trials, men with benign prostatic hyperplasia were randomized to receive ...

Lepor, H. (1998) Phase III Multicenter Placebo-Controlled Study of ...

The purpose of this study is to evaluate the efficacy of Tamsulosin for the treatment of lower ureteric stone of 5 - 10 mm diameter after ESWL. Methods: A total ...

A second phase III multicenter placebo controlled study of 2 ...

A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia.

A second phase III multicenter placebo controlled study of 2 ...

Dive into the research topics of 'A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms ...

Mirabegron Add-on Therapy to Tamsulosin for the Treatment of ...

3. Lepor, H. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group.

A comparison of two phase III multicenter, placebo-controlled ... - OUCI

1996;29:145–154. Lepor H. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia.Urology. 1998;51:892–900.

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients ...

This phase 2b randomised, placebo-controlled trial (RCT) was a dose-response study to assess the efficacy and safety of three different doses of a new ...

Phase III multicenter placebo-controlled study of tamsulosin in ...

Primary efficacy parameters were improvement in the total American Urological Association (AUA) symptom score and peak urinary flow (Qmax). Secondary efficacy ...

Tamsulosin Versus Terazosin for Benign Prostatic Hyperplasia

(1992) A randomized, placebo-controlled multicenter study ... (2001) Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic ...

Tamsulosin for the Treatment of Benign Prostatic Hypertrophy

25. Lepor H. for the Tamsulosin Investigator Group. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology 1998; ...